Latest Posts

Josh Quinlan not cleared for UFC Vegas 59 after steroid metabolite turns up in drug test

- Advertisement -

A pre-fight drug test of UFC welterweight Josh Quinlan revealed trace amounts of the infamous oral turinabol metabolite, prompting the Nevada Athletic Commission to deny him permission to fight Jason Witt at UFC Vegas 59, the UFC said in a statement.

- Advertisement -

Quinlan successfully passed the weigh-ins for Saturday’s event. But according to the statement from the UFC, the promotion was notified by its drug testing partner, the US Anti-Doping Agency, that a “recent” urine sample it submitted contained a “small amount” of the M3 metabolite dehydrochloromethyltestosterone (DHCMT), which is part of an oral steroid that trapped several UFC fighters.

- Advertisement -

USADA has modified its UFC drug testing program to allow up to 100 picograms of M3 in a sample before it is determined to be an adverse finding subject to an anti-doping penalty. But according to the UFC, the commission “determined that Quinlan was not eligible to fight” and canceled the fight. The NAC did not immediately respond to a request for comment on the UFC statement.

- Advertisement -

The UFC later announced that the welterweight bout had been rescheduled for UFC San Diego, taking place on August 13 at the Pechanga Arena in San Diego.

The M3 metabolite has been found in several UFC fighters, most notably former UFC Light Heavyweight Champion Jon Jones, who tested positive for trace amounts of the chemical in drug tests related to his fight against Alexander Gustafsson at UFC 232.

Jones’ swinging results were attributed to increased sensitivity of testing methods, and after careful review, USADA determined that this amount did not improve performance and refused to penalize him. USADA, UFC and NAC subsequently changed their rules to prevent athletes from being tagged with a hard-to-cleanse metabolite that often “pulsed” over time and possibly as a result of weight loss. Flyweight Manel Cape tested positive for a metabolite in connection with the UFC Vegas 52 fight but was not sanctioned due to the changed rules.

In cases where adverse or atypical drug test results come in close to an event, the NAC errs on the side of caution by refusing to clear fighters until it can verify what happened and make an appropriate future licensing decision.



Source: www.mmafighting.com

- Advertisement -

Latest Posts

Don't Miss